agilon health, inc. revised revenue guidance for the full year ending December 31, 2024. For the full year, the company now expects total revenues of $6,350 million to $6,465 million compared to previous guidance of $6,350 million to $6,420 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.19 USD | +4.22% | +4.64% | -58.65% |
05-07 | Transcript : Agilon health, inc., Q1 2024 Earnings Call, May 07, 2024 | |
05-07 | Earnings Flash (AGL) AGILON HEALTH Posts Q1 Revenue $1.60B, vs. Street Est of $1.61B | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.65% | 2.05B | |
-17.30% | 3.12B | |
-12.37% | 3B | |
-25.23% | 331M | |
+4.61% | 241M | |
-46.96% | 183M | |
-32.40% | 113M |
- Stock Market
- Equities
- AGL Stock
- News agilon health, inc.
- Agilon health, inc. Revises Revenue Guidance for the Full Year Ending December 31, 2024